Alys, please keep in mind that I am merely responding to your apparent need to understand both how we got here and where things are headed.
My intent is not to attack anyone, but to instead point out that despite their good intentions, some people have "gone internet" and for quite a while they have failed to make a meaningful contribution to your or my understanding of this stock.
I refuse to act like the proverbial "deer in the headlights" and freeze up (waiting, waiting, waiting for a new CEO).
The new CEO is indeed important. But IMHO the management/activist cat fight is not the only factor influencing this stock at the moment. I listed some other factors in a prior post.
Imagine you were a new investor looking at this stock. Would you pass on making the investment because of management? No, you would have no opinion of management, so that would not be a big issue either way. But you would be concerned about the looming Reg-D cap period, the burn to cash ratio, the "maybe yes, maybe no" clinical trials, and the lack of partners.
The new CEO is not the only near-term event (or lack of event) that will determine the stock price in April of 1998, or 1999, or 2000.
I sure would like management to come out and tell us what the status of both the Lym and TNT trials is. Don't they have a responsibility to do so?
I also agree with shero about margin calls ad their impact on the stock. Both management and activists have probably had some big margin calls the past few months.
--------------------------------------
Or, we can talk some more about what was on 60 Minutes last week! |
